On trouve plusieurs types de produits d'hormonothérapie en vente au Canada, qui contiennent différents oestrogènes et progestines. Ils sont proposés en diverses présentations, en différentes doses et en plusieurs voies d'administration. Il existe des différences importantes d'action pharmacologique entre les diverses hormones et de marqueurs substituts selon la voie d'administration. On peut obtenir le même résultat clinique global avec différentes molécules, mais étant donné l'importante variabilité inter- et intrapatient des produits, il faut personnaliser le traitement pour optimiser les résultats et la qualité de vie de la patiente. (Voir page 14.)
Get full access to this article
View all access options for this article.
References
1.
FitzpatrickLAGoodA. Micronized progesterone: clinical indications and comparison with current treatments. Fertil Steril1999;72(3):389–97.
2.
The PEPI writing group. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA1995;273:199–208.
3.
MontplaisirJLorrainJDenesleRPetitD. Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause2001;8 (1):10–6.
4.
WhiteheadMITownsendPTPryse-DaviesJEffects of various types and dosages of progestogens on the postmenopausal endometrium. J Reprod Med1982;27:539–48.
5.
ArcherDFPickarJHBottiglioniF. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Obstet Gynecol1994;83:686–92.
6.
JensenJChristiansenC. Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy. Am J Obstet Gynecol1988;159:820–5.
7.
JuddHL. Transdermal estradiol: a potentially improved method of hormone replacement. J Reprod Med1994;39:343–52.
8.
WalshBWSchiffIRosnerBEffects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med1991;325:1196–204.
9.
CanonicoMOgerEPlu-BureauGHormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: The ESTHER study. Circulation2007;115:840–5.
10.
SucklingJLethabyAKennedyR. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev2006;(4):CD001500.
11.
North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement. Menopause2010; 17:242–55.
